Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | AKKARAJU SRINIVAS | Sep 8, 2026 | Sell | $507.02K | 48,066 |
| Director | AKKARAJU SRINIVAS | Sep 8, 2026 | Sell | $507.01K | 48,065 |
| Director | AKKARAJU SRINIVAS | Sep 8, 2026 | Buy | $2.9M | 273,291 |
| Director | AKKARAJU SRINIVAS | Sep 8, 2026 | Buy | $2.9M | 273,290 |
| Director | AKKARAJU SRINIVAS | Sep 4, 2026 | Buy | $2.46M | 220,070 |
| Director | AKKARAJU SRINIVAS | Sep 4, 2026 | Buy | $2.46M | 220,070 |
| Chief Business & Strategy Ofcr | Hardiman Roy C. | Aug 3, 2026 | Sell | $70.99K | 2,692 |
| CFO | Schroer John R. | Aug 3, 2026 | Sell | $86.55K | 3,282 |
| Chief Scientific Officer | Goldstein David M | Aug 3, 2026 | Sell | $68.46K | 2,596 |
| Chief Medical Officer | Drappa Jorn | Aug 3, 2026 | Sell | $64.53K | 2,447 |
| Chief Legal Officer | Pangali Sanam | Aug 3, 2026 | Sell | $35.97K | 1,364 |
| Chief Development Officer | Bradley Mark Christopher | Aug 3, 2026 | Sell | $67.82K | 2,572 |
| Chief Legal Officer | Pangali Sanam | Jul 6, 2026 | Sell | $140K | 5,000 |
| Director | AKKARAJU SRINIVAS | Jan 9, 2026 | Buy | $10M | 588,235 |
| 10% Owner | Foresite Labs, LLC | Jan 8, 2026 | Buy | $2M | 117,647 |
| Director | Tananbaum James B. | Jan 8, 2026 | Buy | $2M | 117,647 |
| 10% Owner | Foresite Capital Management VI LLC | Jan 8, 2026 | Buy | $2M | 117,647 |
| 10% Owner | Foresite Labs, LLC | Jan 8, 2026 | Buy | $5M | 294,117 |
| 10% Owner | Foresite Capital Management VI LLC | Jan 8, 2026 | Buy | $5M | 294,117 |
| Director | Tananbaum James B. | Jan 8, 2026 | Buy | $5M | 294,117 |
| Director | AKKARAJU SRINIVAS | Dec 5, 2025 | Buy | $581.47K | 64,969 |
| Director | AKKARAJU SRINIVAS | Dec 5, 2025 | Buy | $700.98K | 70,028 |
| Director | AKKARAJU SRINIVAS | Dec 5, 2025 | Buy | $551.31K | 51,380 |
| Director | AKKARAJU SRINIVAS | Dec 4, 2025 | Buy | $540.1K | 66,027 |
| Director | AKKARAJU SRINIVAS | Dec 3, 2025 | Buy | $775K | 100,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
